Bortezomib
Failed stability specifications
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Lack of Sterility Assurance
Cause type: Sterility / contamination
A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.
Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
Compare with the code on your package — it is the most precise check available.
Drug: Bortezomib
From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.
| Product | Strength | Form & route | Labeler | Type |
|---|---|---|---|---|
| Bortezomib NDC 70069-0836 |
3.5 mg/3.5mL | Injection, Powder, Lyophilized, for Solution Intravenous|subcutaneous |
Somerset Therapeutics LLC | Rx |
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.
Failed stability specifications
Lack of Assurance of Sterility
Defective Container: Confirmed reports of loose vial crimps.
Lack of Sterility Assurance
Lack of Sterility Assurance
Lack of Sterility Assurance
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.